|
MechanismPGI2 receptor agonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date21 May 2002 |
Target- |
Mechanism- |
|
|
Active Indication- |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
Active Indication- |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Shanghai ForeFront Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Shanghai ForeFront Pharmaceutical Co., Ltd.
100 Deals associated with Shanghai ForeFront Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Shanghai ForeFront Pharmaceutical Co., Ltd.